Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Kodiak Sciences Inc.

91.08
-1.2600-1.36%
Pre-market: 90.45-0.6300-0.69%07:27 EDT
Volume:1.31M
Turnover:120.27M
Market Cap:5.70B
PE:-21.91
High:94.25
Open:91.74
Low:89.91
Close:92.34
52wk High:104.00
52wk Low:10.94
Shares:62.58M
Float Shares:36.99M
Volume Ratio:0.41
T/O Rate:3.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1571
EPS(LYR):-4.3220
ROE:-368.37%
ROA:-60.45%
PB:93.29
PE(LYR):-21.07

Loading ...

OverviewCompanyNewsFilings

Kodiak Sciences price target raised to $112 from $56 at Jefferies

TIPRANKS
·
Sep 29

Kodiak Sciences Price Target Raised to $96.00/Share from $58.00 by HC Wainwright & Co.

Dow Jones
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)

TIPRANKS
·
Sep 29

Kodiak Sciences Inc. : H.c. Wainwright Raises Target Price to $96 from $58

THOMSON REUTERS
·
Sep 28

Top Midday Stories: MongoDB CEO Leaves to Lead Meta Enterprise Platform; Nvidia Ups Buyback Program by $150 Billion

MT Newswires Live
·
Sep 28

Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%

Dow Jones
·
Sep 28

Movement Alert｜Kodiak Sciences Inc. Surges 146.43% in Regular Trading, Two Eye Drug Candidates Meet Primary Endpoints in Phase 3 Trial

Market Focus
·
Sep 28

Kodiak Sciences Shares Hit 52-Week High After Positive Phase 3 Trial

Dow Jones
·
Sep 28

Kodiak Sciences up Nearly 154%, on Pace for Record Percent Increase

Dow Jones
·
Sep 28

Kodiak Sciences rises 136.7%

TIPRANKS
·
Sep 28

Kodiak Sciences Shares up 123% After Co's Eye-Disease Drugs Meet Trial Goals

THOMSON REUTERS
·
Sep 28

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Oil Prices Rise

MT Newswires Live
·
Sep 28

Sector Update: Healthcare

MT Newswires Live
·
Sep 28

Nvidia, Meta, SpaceX, Kodiak Sciences, MongoDB, Boeing, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 28

The Stock Market Faces a Triple Threat but it Can Emerge Victorious

Dow Jones
·
Sep 28

Top Premarket Gainers

MT Newswires Live
·
Sep 28

Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals

Reuters
·
Sep 28

Kodiak Sciences Shares up 32% Premarket After Zenkuda and Tabirafusp-Ted Meet Primary Endpoints in Daybreak Trial in Wet Age-Related Macular Degeneration

THOMSON REUTERS
·
Sep 28

Kodiak Sciences Says Zenkuda Meets Primary Endpoint in Phase 3 Daybreak Wet AMD Trial

Reuters
·
Sep 28

Zenkuda and Tabirafusp-Ted Meet Primary Endpoints in Pivotal Daybreak Trial in Wamd, with Zenkuda Demonstrating a Potential New Standard-of-Care Profile with Strong Immediacy and Sustained Clinical Effect with Majority of Patients on 24-Week Dosing Interval Using Strict Treat-to-Dryness Real World Retreatment Criteria.

THOMSON REUTERS
·
Sep 28
More